2m 2m 2m 2m 2m 2m 2m
ANAPTYSBIO (ANAB)
NASDAQ
$49.20-$0.005 (-0.01%)
Price as of Oct 05, 2026 7:30 PM EDT- $1.5BMarket Cap
- 62.64%1-Year Change
- BiotechnologyIndustry
ANAPTYSBIO (ANAB)
$49.20-$0.005 (-0.01%)
Annual
Quarterly
06/30/2026 | 12/31/2025 | 12/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 53.0M -77.39% | 234.6M +157.01% | 91.3M +432.03% | 17.2M +66.78% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 53.0M -77.39% | 234.6M +157.01% | 91.3M +432.03% | 17.2M +66.78% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | -136.0M -17.01% | -163.8M +23.86% | -132.3M +48.97% | |
Depreciation and Amortization Expense | 9,000 -98.39% | 559,000 -7.76% | 606,000 -7.06% | 652,000 -3.41% | |
Total Operating Expenses | 20.7M -88.90% | 186.7M -9.47% | 206.2M +13.58% | 181.6M +44.74% | |
Operating Profit | 32.3M +344.27% | -13.2M -88.49% | -114.9M -30.08% | -164.4M +42.77% | |
Interest Income | 3.3M -75.91% | 13.5M -31.80% | 19.8M +4.88% | 18.9M +149.97% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 3.3M -75.91% | 13.5M -31.80% | 19.8M +4.88% | 18.9M +149.97% | |
Total Nonoperating Income and Expense | -37.4M -38.63% | -61.0M +101.34% | -30.3M -3,942.51% | 788,000 +105.82% | |
Income before Taxes | -5.1M -61.51% | -13.2M -90.89% | -145.2M -11.24% | -163.6M +27.14% | |
Income Taxes | -181.5M -110,740.85% | 164,000 +5,366.67% | 3,000 +175.00% | -4,000 -116.67% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 131.0M +1,089.99% | -13.2M -90.89% | -145.2M -11.24% | -163.6M +27.11% | |
Net Income from Continuing Operations Applicable to Common | 176.4M +1,432.81% | -13.2M -90.89% | -145.2M -11.24% | -163.6M +27.14% | |
Basic EPS and Net Income | 4.52 +1,082.61% | -0.46 -91.02% | -5.12 -15.79% | -6.08 +33.04% | |
Diluted EPS and Net Income | 3.50 +860.87% | -0.46 -91.02% | -5.12 -15.79% | -6.08 +33.04% | |
Basic Weighted Average Shares | 29.0M +0.77% | 28.8M +1.32% | 28.4M +5.42% | 26.9M -4.41% | |
Diluted Weighted Average Shares | 37.5M +30.32% | 28.8M +1.32% | 28.4M +5.42% | 26.9M -4.41% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 133.8M -43.82% | 238.2M +93.53% | 123.1M +242.22% | 36.0M -49.56% | |
Short-Term Investments | 30.3M -58.72% | 73.4M -72.00% | 262.3M -26.10% | 354.9M -4.05% | |
Cash and Cash Equivalents and Short-Term Investments | 164.1M -47.33% | 311.6M -19.13% | 385.4M -1.41% | 390.9M -11.41% | |
Total Current Assets | 198.4M -43.35% | 350.3M -18.90% | 431.9M +6.16% | 406.8M -9.03% | |
Accumulated Depreciation | 101,000 -98.59% | 7.1M +8.18% | 6.6M +6.13% | 6.2M +11.51% | |
Property and Plant and Equipment and Net | 102,000 -92.55% | 1.4M -25.91% | 1.8M -11.87% | 2.1M +0.43% | |
Total Long-Term Assets | 256,000 0.00% | 256,000 0.00% | 256,000 0.00% | 256,000 0.00% | |
Total Assets | 317.0M -13.01% | 364.4M -24.69% | 483.8M +6.95% | 452.4M -25.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 35.4M -8.47% | 38.6M -14.98% | 45.4M +21.33% | 37.4M +43.71% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 10.9M -9.13% | 12.0M -14.74% | 14.1M -12.00% | 16.0M -9.97% | |
Total Liabilities | 46.3M -8.63% | 50.7M -14.92% | 59.5M +11.33% | 53.5M +21.91% | |
Retained Earnings | -641.6M -16.96% | -772.6M +1.74% | -759.3M +23.65% | -614.1M +36.32% | |
Total Stockholders Equity | 10.6M -71.55% | 37.2M -47.49% | 70.9M -19.56% | 88.1M -66.39% | |
Total Shares Outstanding | 29.7M +6.10% | 28.0M -8.05% | 30.5M +14.57% | 26.6M -6.72% | |
Cash Flow | |||||
Cash from Operating Activities | -52.6M -366.84% | 19.7M +114.55% | -135.3M +12.03% | -120.8M +64.15% | |
Capital Expenditures | N/A N/A | 87,000 -75.70% | 358,000 -55.64% | 807,000 +125.42% | |
Cash from Investing Activities | 42.5M -81.34% | 228.0M +139.03% | 95.4M -34.10% | 144.8M +136.66% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -94.4M -28.85% | -132.6M -204.38% | 127.1M +314.27% | -59.3M -234.71% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 60.93% +1,180.36% | -5.64% -95.52% | -125.93% -86.86% | -958.27% -14.39% | |
Return on Assets | 38.45% +1,332.42% | -3.12% -89.94% | -31.02% +0.76% | -30.79% +49.91% | |
Return on Equity | 548.16% +2,338.66% | -24.49% -86.60% | -182.71% +95.54% | -93.44% +124.50% | |
Revenue Growth | -77.39% -149.29% | 157.01% -63.66% | 432.03% +546.91% | 66.78% +179.77% | |
Current Ratio | 5.61 -38.10% | 9.07 -4.62% | 9.51 -12.51% | 10.87 -36.70% | |
Cash Ratio | 3.79 -38.62% | 6.17 +127.62% | 2.71 +182.04% | 0.96 -64.90% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow